Pasithea Therapeutics Operating Expenses Growth & History (KTTA)
Pasithea Therapeutics's operating expenses was $20.9M for fiscal 2025.
View full Pasithea Therapeutics company overviewPasithea Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.9M | $6.6M | +46.37% |
| 2024 | 2024-12-31 | $14.2M | −$1.7M | −10.82% |
| 2023 | 2023-12-31 | $16.0M | $3.0M | +23.28% |
| 2022 | 2022-12-31 | $13.0M | $8.5M | +187.72% |
| 2021 | 2021-12-31 | $4.5M | — | — |
Pasithea Therapeutics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.7M | $1.9M | +49.92% |
| Q1 2026 | 2026-03-31 | $4.9M | $1.2M | +32.51% |
| Q4 2025 | 2025-12-31 | $10.3M | — | — |
| Q3 2025 | 2025-09-30 | $3.1M | — | — |
| Q2 2025 | 2025-06-30 | $3.8M | — | — |
| Q1 2025 | 2025-03-31 | $3.7M | — | — |
| Q4 2022 | 2022-12-31 | $4.3M | — | — |
| Q3 2022 | 2022-09-30 | $4.0M | — | — |
| Q2 2022 | 2022-06-30 | $2.6M | — | — |
| Q1 2022 | 2022-03-31 | $2.1M | — | — |
Pasithea Therapeutics operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Pasithea Therapeutics's operating expenses increased from $4.5M to $20.9M, a change of $16.4M. The latest reported quarter, Q2 2026, shows $5.7M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pasithea Therapeutics source filings ↗